Loading…

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Thursday, September 10
 

7:15am PDT

Welcome Session with Breakfast

Join Drs. Rakesh Jain and Charles Raison, 2015 Psych Congress Co-Chairs, as they kick off the 28th Annual U.S. Psychiatric and Mental Health Congress with their welcome address.


Moderators
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressClinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine,  Midland, TexasDr. Rakesh Jain attended medical school at the University of Calcutta in India and attended graduate school... Read More →
avatar for Charles Raison, MD

Charles Raison, MD

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressMike and Mary Sue Endowed Chair in Mind, Body, and Family Well-being Professor; School of Human Ecology Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin, Madison, WisconsinDr... Read More →

Thursday September 10, 2015 7:15am - 9:00am PDT
20D

9:15am PDT

First-Episode Psychosis 2015: Risk, Prodrome, Treatment, and Outcome
Multidisciplinary programs from 5 continents—dedicated to the identification and treatment of individuals at high risk of or entering first episodes of psychosis—have recently reported their 10-year outcome data. The Recovery After an Initial Schizophrenia Episode (RAISE) program is a National Institute of Mental Health research project testing the value of youth-centered strategies focused on education, employment support, as well as the preservation of function and avoidance of disability. These new data suggest that early identification and engagement of these individuals and practice redesign with novel multidisciplinary treatment teams can significantly reduce the disabling outcomes of psychotic illness. This session will discuss the importance of early identification of individuals at high risk of or entering a first episode of psychosis, which shortens the duration of untreated psychosis. Dr. McEvoy will focus on multidisciplinary strategies for the successful engagement of these individuals into treatment programs that integrate minimal or no adverse effect pharmacotherapy, with attention to and support for these young individuals’ priorities (eg, education and employment, social life, independent living), offering the greatest opportunity to favorably influence the course and outcomes of psychotic disorders.

Speakers
avatar for Joseph McEvoy, MD

Joseph McEvoy, MD

Professor of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina; Staff Psychiatrist, Central Regional Hospital, Butler, North CarolinaJoseph P. McEvoy, MD, currently holds the Case Distinguished Chair in Psychotic Disorders at the Medical College... Read More →


Thursday September 10, 2015 9:15am - 10:30am PDT
30E

9:15am PDT

Transcranial Magnetic Stimulation in Clinical Practice: Past, Present, and Future

Transcranial magnetic stimulation (TMS) is an emerging treatment that has shown great promise for patients with treatment-resistent depression (TRD), yet many mental health professionals remain unclear as to how and when this therapuetic option should be utilized. Is TMS an appropriate option for your patients with complex depression? Should you refer patients with TRD for TMS? Would a TMS device benefit your practice? This session will seek to answer these questions by focusing on the history of TMS, reviewing the evidence-based data related to its use in TRD, and exploring novel research that may extend the use of TMS beyond therapy for TRD.


Moderators
avatar for Jon W. Draud, MD, MS

Jon W. Draud, MD, MS

Clinical Professor of Psychiatry, University of Tennessee College of Medicine, Memphis, Tennessee; Medical Director of Psychiatry, Trust Point Psychiatric Hospital and St. Thomas Rutherford Hospital; Medical Director and Principal, Evelyn Frye Associates; Private Practice, Adult and... Read More →

Thursday September 10, 2015 9:15am - 10:30am PDT
29D

9:15am PDT

Obesity and Depression: Can Diet Change Mood?

It is no coincidence that 3 out of every 4 depressed patients in the United States are overweight. Yet, we as mental health professionals often neglect this key area of practice, focusing strictly on the mind and ignoring the body. Systemic inflammation has long been associated with and has been found to perpetuate depression, and a growing body of data indicates that one of the principal sources of inflammation is obesity, particularly visceral fat mass. In this evidence-based session, Dr. Shelton will highlight strategies for incorporating obesity as an end point for the treatment of depression and offer practical ways to prescribe a diet and exercise regimen designed to improve depressed mood.


Speakers
avatar for Richard Shelton, MD

Richard Shelton, MD

Charles B. Ireland Professor & Vice Chair for Research, Department of Psychiatry, University of Alabama at Birmingham, Birmingham, AlabamaRichard C. Shelton, MD attended medical school at the University of Louisville in Kentucky. He, then, travelled to Boston, where he became a resident... Read More →


Thursday September 10, 2015 9:15am - 10:30am PDT
28E

10:45am PDT

The Current State of Antidepressant Therapy 2015
Depression is one of the world’s greatest public health problems. As antidepressants are one of the most widely prescribed classes of medications, even modest differences in efficacy or tolerability have important implications. This session will summarize the state-of-the-art antidepressant therapy and touch on areas of controversy. Dr. Thase will also discuss the issues affecting signal detection in antidepressant trials and review each of the major classes of antidepressants, including more newly released drugs and novel therapeutic compounds, such as ketamine and related drugs.

Speakers
avatar for Michael Thase, MD

Michael Thase, MD

Professor of Psychiatry, Perelman School of Medicine University of Pennsylvania, Philadelphia, PennsylvaniaMichael E. Thase, MD, joined the faculty of the University of Pennsylvania School of Medicine in January, 2007 as Professor of Psychiatry and Director of the Department of Psychiatry’s... Read More →


Thursday September 10, 2015 10:45am - 12:00pm PDT
20A

10:45am PDT

Managing Psychiatric Disturbances Associated with Neurocognitive Disorders

The majority of individuals suffering from a neurocognitive disorder face associated psychiatric disturbances at some point in the course of their disease. Timely recognition of the presence of depression, anxiety, agitation, psychosis, and apathy within the context of a neurocognitive disorder is essential. While the treatment of these disturbances may follow the form of that for individuals without cognitive impairment, it often involves unique approaches in order to optimize outcomes. This session will review key considerations for the selection and dosing of psychotropic medications for major psychiatric illnesses associated with neurocognitive disorders. Strategies for minimizing adverse effects of treatment, particularly in elderly individuals, will also be discussed.


Speakers
avatar for Marc E. Agronin, MD

Marc E. Agronin, MD

Medical Director for Mental Health and Clinical Research, Miami Jewish Health Systems, Miami, Florida; Affiliate Associate Professor of Psychiatry and Neurology, University of Miami Miller School of Medicine, Miami, FloridaMarc Agronin, MD is a geriatric psychiatrist and the author... Read More →


Thursday September 10, 2015 10:45am - 12:00pm PDT
30E

10:45am PDT

Translating Advances in Neuroscience into Clinical Practice

With rapid advances being made in basic neuroscience research, it is often difficult for clinicians to remain abreast of these findings. The advances made in these areas are increasingly impacting clinical practice in terms of how we consider and formulate diagnoses and treatment plans. This session will provide specific information translating some of the most important recent neuroscience advances to clinical practice. Strategies for providing informed council to patients about how recent neuroscience research advances impact their treatment course will also be discussed.


Speakers
avatar for Gerard Sanacora, MD, PhD

Gerard Sanacora, MD, PhD

Professor, Yale University, Director, Yale Depression Research Program, New Haven, ConnecticutGerard Sanacora, MD, PhD, completed an National Institutes of Health (NIH)-sponsored Medical Scientist Training Program at the State University New York at Stony Brook, earning his Doctorate... Read More →


Thursday September 10, 2015 10:45am - 12:00pm PDT
29D

10:45am PDT

Beyond First-Line Therapy: Managing Complex Insomnia in the Mental Health Setting

Sleep disturbances remain common problems among patients with mental health disorders. The challenges in providing effective treatment to these patients may relate to the use of medications that may not optimally address a patient’s symptom complex. Knowledge about comorbid conditions that may complicate insomnia therapy and the pharmacological properties of available insomnia medications are essential to formulating effective treatment plans. This session will explore these treatment challenges, reviewing the multiple influences that may contribute to difficulty with sleep onset and maintenance. Dr. Neubauer will review a variety of therapeutic options, and will include an update on the pharmacodynamics and pharmacokinetics of medications approved for insomnia treatment.


Speakers
avatar for David Neubauer, MD

David Neubauer, MD

Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MarylandDavid Neubauer, MD is an Associate Professor of Psychiatry at the Johns Hopkins University School of Medicine and Associate Director of the Johns Hopkins Sleep Disorders... Read More →


Thursday September 10, 2015 10:45am - 12:00pm PDT
28E

12:15pm PDT

ISS: Mixed Features in Depressive Episodes: Managing Patients Across the Disease Spectrum

As many as half of patients experiencing a major depressive episode will have 3 or more subsyndromal manic or hypomanic symptoms, complicating the diagnosis and treatment choices. In an effort to better define this patient cohort, the latest version of the Diagnostic and Statistical Manual of Mental Disorders includes the option of the “with mixed features” specifier for patients experiencing depressive episodes. The goal of this Evidence-Based Best-Practices™ program is to provide psychiatrists and other health care providers with practical recommendations for identifying depressed patients with mixed features and tailoring evidence-based therapy to address their subsyndromal symptoms.

This activity is supported by an educational grant from Sunovion Pharmaceuticals, Inc.


Speakers
avatar for Michael Thase, MD

Michael Thase, MD

Professor of Psychiatry, Perelman School of Medicine University of Pennsylvania, Philadelphia, PennsylvaniaMichael E. Thase, MD, joined the faculty of the University of Pennsylvania School of Medicine in January, 2007 as Professor of Psychiatry and Director of the Department of Psychiatry’s... Read More →
avatar for Joseph Calabrese, MD

Joseph Calabrese, MD

Bipolar Disorders Research Chair; Professor, Department of Psychiatry; Director, Mood Disorders Program; University Hospitals Case Medical Center; Case Western Reserve University School of Medicine, Cleveland, Ohio
avatar for Gary S. Sachs, MD

Gary S. Sachs, MD

Associate Clinical Professor of Psychiatry, Harvard Medical School; Founding Director, Bipolar Clinic and Research Program, Massachusetts General Hospital, Boston, Massachusetts 


Thursday September 10, 2015 12:15pm - 2:00pm PDT
20D

12:15pm PDT

ISS: Targeting Residual Symptoms in Major Depressive Disorder

Many patients with major depressive disorder (MDD) continue to have residual symptoms despite meeting criteria for remission. The goal of this symposium is to help mental health professionals develop and implement individualized management strategies for patients with MDD. Topics will focus on how to assess and identify residual symptoms using evidence-based screening tools and rating scales, as well as data on newer and emerging treatments.

Psychopharmacology Credit: 1.0

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.


Co-Chairs
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressClinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine,  Midland, TexasDr. Rakesh Jain attended medical school at the University of Calcutta in India and attended graduate school... Read More →


Thursday September 10, 2015 12:15pm - 2:00pm PDT
20BC

2:15pm PDT

Re-imagining a Brave New World: Can Psychedelics be Catalysts for Therapy

Can medications be used to accelerate the psychotherapeutic process? Psychotherapy catalyzed by psychedelic drugs has received considerable attention recently in both the evidenced-based literature and popular press. Because these drugs are typically only described as drugs of abuse, most mental health professionals know little of their potential therapeutic benefit. How could these compounds—historically associated with both traditional plant medicine and substance abuse—be useful to accelerate the psychotherapeutic process? This session will explore this question by examining the pharmacology, mechanism of action, and neurobiology of psilocybin, 3,4,-methylenedioxymethamphetmine (MDMA), and other psychedelic compounds, and their potential use in the treatment of end-of-life anxiety, posttraumatic stress disorder, and substance dependence.


Moderators
avatar for Andrew Penn, RN, MS, NP, APRN-BC

Andrew Penn, RN, MS, NP, APRN-BC

Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CAAndrew Penn was trained as an adult nurse practitioner and psychiatric clinical nurse specialist at the University of California, San Francisco... Read More →

Thursday September 10, 2015 2:15pm - 3:30pm PDT
29D

2:15pm PDT

Reducing Burden of Antipsychotic Medications: An Integated Approach to Addressing Adverse Effects
Often adverse effects of medications are presented as lists and tables, and while useful, do not by themselves guide clinical assessment and management. Adverse effects are a major part of the decision-making process, but the assessment and management also need to take into acccount efficacy, risks, patient goals, and the therapeutic alliance, as well as the relative effectiveness of interventions. This session will address assessment and management of adverse effects of antipsychotic medications within the larger context of decisions that also have to take into account risks of intervention on efficacy and other possible adverse effects.

Speakers
avatar for Peter Weiden, MD

Peter Weiden, MD

Professor of Psychiatry, University of Illinois Medical Center, Chicago, IllinoisPeter J. Weiden, MD is a Professor of Psychiatry at the University of Illinois Medical Center in Chicago. He is also the Chief Medical Officer at Uptown Research, a clinical trials program specializing... Read More →


Thursday September 10, 2015 2:15pm - 3:30pm PDT
20A

2:15pm PDT

Autism and Intellectual Disability Throughout the Lifespan

The number of people with autism and intellectual disability has shown a dramatic increase in prevalence in the past 20 years. Once viewed as the province of pediatric trained mental health specialists, practitioners are increasingly asked to manage the growing number of patients with these mental disorders and their comorbidities as they age beyond adolescence to older age and often feel poorly prepared to do so. This session will describe key developmental lines and ways to help patients and their families with the complex mental health challenges throughout the lifespan.


Speakers
avatar for Robert Hendren, DO

Robert Hendren, DO

Professor of Psychiatry, Director, Division Child and Adolescent Psychiatry,  University of California, San Francisco, San Francisco, CaliforniaRobert L. Hendren, DO, is Professor of Psychiatry and Behavioral Science, Director of Child and Adolescent Psychiatry, Director of the Autism... Read More →


Thursday September 10, 2015 2:15pm - 3:30pm PDT
30E

2:15pm PDT

Exercise Prescription for Major Depressive Disorder

The use of exercise in the treatment of major depressive disorder (MDD) has gained support, as evidenced by the inclusion of exercise treatment in the American Psychiatric Association’s most recent treatment guidelines. However, data suggest that mental health professionals infrequently prescribe or discuss exercise with their patients. This session will review the current evidence supporting exercise in the treatment of MDD. Dr. Rethorst will also highlight strategies to effectively prescribe exercise to patients with MDD by including interactive activities in this session.


Speakers
avatar for Chad Rethorst, PhD

Chad Rethorst, PhD

Assistant Professor, University of Texas Southwestern Medical Center, Dallas, TexasChad D. Rethorst, PhD is an Assistant Professor in the Department of Psychiatry at the University of Texas Southwestern (UTSW) Medical Center at Dallas. He obtained his doctorate in Kinesiology from... Read More →


Thursday September 10, 2015 2:15pm - 3:30pm PDT
28E

3:45pm PDT

Consequences of Public Disclosure of Mental Illness

Writing a memoir about mental illness, especially if one is a professor of psychiatry, has consequences. Responses to one such, An Unquiet Mind, were many and complicated. From colleagues, they ranged from compassion and encouragement to criticism and silence. Public response ranged from support and appreciation to religious and political tirades. It is not surprising that students and young doctors with mental illness continue to express deep concern about the consequences of seeking treatment or talking openly with their clinical supervisors, mentors, or professors. By sharing her own battles with bipolar disorder, Dr. Jamison will explore the benefits and consquences of publically disclosing mental illness.


Speakers
avatar for Kay Redfield Jamison, PhD

Kay Redfield Jamison, PhD

The Dalio Family Professor of Mood Disorders, Professor of Psychiatry, The Johns Hopkings University School of Medicine, Baltimore, MarylandKay Redfield Jamison, PhD, is the Dalio Family Professor in Mood Disorders, Professor of Psychiatry at the Johns Hopkins University School of... Read More →


Thursday September 10, 2015 3:45pm - 5:00pm PDT
20A

5:15pm PDT

Opening Night Reception in the Exhibit Hall
Thursday September 10, 2015 5:15pm - 6:45pm PDT
Exhibit Hall San Diego Convention Center
 
Friday, September 11
 

7:30am PDT

ISS: Cognitive Impairment Associated with Schizophrenia: Targeting Symptoms to Improve Patient Outcomes

Join Dr. Maletic and Dr. McEvoy as they discuss the latest evidence on investigational therapies for cognitive impairment associated with schizophrenia. An in-depth review of developing insights into the pathophysiology and neurobiology of schizophrenia and potential targets for cognitive enhancement will be discussed, as well as the importance of employing validated measurement tools to better identify treatment gaps in symptom domains, cognitive functioning, and medication adherence to maximize quality of life and maintain recovery.

Psychopharmacology Credit: 1.25

This activity is supported by an educational grant from FORUM Pharmaceuticals.


Speakers
avatar for Joseph McEvoy, MD

Joseph McEvoy, MD

Professor of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina; Staff Psychiatrist, Central Regional Hospital, Butler, North CarolinaJoseph P. McEvoy, MD, currently holds the Case Distinguished Chair in Psychotic Disorders at the Medical College... Read More →

Steering Committee
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina; Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, North CarolinaDr. Vladimir... Read More →


Friday September 11, 2015 7:30am - 9:15am PDT
20BC

7:30am PDT

ISS: Evolving Strategies for Improved Schizophrenia Care: Focus on Symptom Domains and Tolerability

Join Dr. Jackson and Dr. Kane as they discuss symptoms of schizophrenia and its impact on treatment outcomes and quality of life. The goal of this session is to help mental healthcare professionals stay up-to-date on newer antipsychotics and translate available clinical data to a patient-centric selection of antipsychotic therapies to improve adherence and treatment outcomes.

Psychopharmacology Credit: 1.25

This activity is supported by an educational grant from Allergan.



Friday September 11, 2015 7:30am - 9:15am PDT
20D

9:30am PDT

Treatment Non-Adherence in Bipolar Illness

Non-adherence is the primary clinical problem associated with treating bipolar illness. This talk will discuss the extent of the problem, the reasons for it, and the best strategies for increasing the likelihood of adherence.


Speakers
avatar for Kay Redfield Jamison, PhD

Kay Redfield Jamison, PhD

The Dalio Family Professor of Mood Disorders, Professor of Psychiatry, The Johns Hopkings University School of Medicine, Baltimore, MarylandKay Redfield Jamison, PhD, is the Dalio Family Professor in Mood Disorders, Professor of Psychiatry at the Johns Hopkins University School of... Read More →


Friday September 11, 2015 9:30am - 10:45am PDT
20A

11:00am PDT

ADHD Across the Lifespan: Focus on Long-Term Outcomes

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder presenting for treatment in children and adolescents, and is a growing presentation in adults. However, few mental health professionals currently feel comfortable diagnosing ADHD across the lifespan; and even fewer are comfortable with their knowledge base on treatment strategies for these patients. Little is known by mental health professionals about the long-term effects of chronic treatment on the course and associated problems of ADHD despite an expanding international literature. This session will provide an update on the course, comorbidity, and long-term treatment of ADHD.


Speakers
avatar for Timothy Wilens, MD

Timothy Wilens, MD

Chief, Child and Adolescent Psychiatry, Co-Director, Center for Addiction Medicine, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School, Boston, MassachussettsTimothy E. Wilens, MD, is Chief of Child and adolescent Psychiatry, and (Co) Director... Read More →


Friday September 11, 2015 11:00am - 12:15pm PDT
28E

11:00am PDT

Social Anxiety Disorder: Out of the Shadows
Social anxiety disorder (SAD) is the most common of the anxiety disorders. It has an early onset and is typically associated with the subsequent occurrence of complications such as major depression and substance use problems. However, its presentation in clinical practice can be subtle, and it is important to be able to recognize and treat SAD appropriately in order to prevent disability. Dr. Stein will review the current thinking around prevalence, diagnosis, and epidemiology of SAD in order to apply current approaches to treatment in everyday practice.

Speakers
avatar for Murray B. Stein, MD

Murray B. Stein, MD

Professor of Psychiatry and Family and Preventive Medicine, University of California, San Diego; Staff Psychiatrist, VA San Diego Healthcare System, La Jolla, CaliforniaMurray B. Stein MD, MPH, FRCPC, is Professor of Psychiatry and Family and Preventive Medicine at the University... Read More →


Friday September 11, 2015 11:00am - 12:15pm PDT
20A

11:00am PDT

Microbes for Mental Health: An Update on the Role of Gut Microbiota Modulation for the Treatment and Prevention of Mood and Anxiety Disorders

Ongoing clinical and research priorities in psychiatry are identifying and leveraging factors that influence illness trajectory and outcome. With depressive disorders as the leading source of disability globally, the identification of new targets for prevention and management is imperative. A rapidly emerging field of research suggests that the microbiome-gut-brain axis is of substantial relevance to mood and behavior. The evolving concept of a microbiota-gut-brain axis indicates that modulation of the gut microbiota may provide novel therapeutic targets for the treatment and/or prevention of mood and anxiety disorders. This session will describe the association between dysfunction of the microbiota-gut-brain axis and stress-related disorders (ie, depression, anxiety disorders, and irritable bowl syndrome) and neurodevelopmental disorders (ie, austism spectrum disorders). Dr. Scheiderer will discuss how to utilize prebiotics, probiotics, antibiotics, fecal transplants, and dietary changes to manipulate gut microbiota, as well as provide insight on when, how, and in which patients to incorporate gut strategies for the evaluation and treatment of psychiatric illness.


Speakers
avatar for David Scheiderer, MD

David Scheiderer, MD

Director of Education, Integrative Psychiatry, Sarasota, FloridaDavid J. Scheiderer, MD, MBA, DFAPA, is the Director of Education at Integrative Psychiatry, Inc. in Sarasota, Florida and the President of Tiberius Enterprises, Inc. in Roanoke, Virginia. An accomplished clinician, educator... Read More →


Friday September 11, 2015 11:00am - 12:15pm PDT
30E

11:00am PDT

Telemedicine Delivery of Evidence-based Psychiatric and Behavioral Treatments for PTSD: Pitfalls, Best Practices, and Outcomes

Health disparities arising from geographic isolation, travel and parking expense, and simple logistics related to not being able to get to and from treatment sites are being addressed through adaptation of best practice treatments to telemedicine formats. However, this process has been unnecessarily slowed by administrative and clinical fears related to patient safety, reimbursement, and limits of technology. In this interactive session, Drs. Acierno and Hamner will discuss common issues confronting psychiatric and behavioral providers using telemedicine to treat posttraumatic stress disorder (PTSD) and other related disorders, including suicidality and safety risk, technology requirements and barriers, modifications to content and style, billing and reimbursement standards, and lessons learned. Emerging data comparing outcomes of televideo vs. in-person treatments will also be covered.


Speakers
avatar for Mark B. Hamner, MD

Mark B. Hamner, MD

Professor, Military Sciences Division, Medical University of South Carolina, Charleston, South CarolinaMark B. Hamner, MD is a Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC) in Charleston. He is also Medical Director... Read More →
avatar for Ron Acierno, PhD

Ron Acierno, PhD

Senior Researcher, PTSD Clinical Team, Ralph H. Johnson VA Medical Center, Charleston, South Carolina; Professor and Associate Dean for Research, College of Nursing at the Medical University of South Carolina, Charleston, South Carolina; Founder and Clinical Director, Veterans on... Read More →


Friday September 11, 2015 11:00am - 12:15pm PDT
29D

12:30pm PDT

Professional Medical Education (PME) Presentations

Non-CME. Lunch will be served. Seating is limited.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives and assess the value to your patient care. Seating is limited and available on a first come, first served basis. PME presentations are not intended or eligible for CME/CE credit.


Friday September 11, 2015 12:30pm - 1:45pm PDT
TBD1 San Diego Convention Center

12:30pm PDT

Exhibit Hall
Friday September 11, 2015 12:30pm - 2:30pm PDT
Exhibit Hall San Diego Convention Center

12:30pm PDT

Poster Pavilion
Friday September 11, 2015 12:30pm - 2:30pm PDT
Exhibit Hall San Diego Convention Center

1:30pm PDT

Poster Presentations
Friday September 11, 2015 1:30pm - 2:30pm PDT
Exhibit Hall San Diego Convention Center

2:00pm PDT

Psych Congress Network Live!
Friday September 11, 2015 2:00pm - 2:30pm PDT
Exhibit Hall San Diego Convention Center

2:45pm PDT

Top 5 Challenges in Treatment of Patients with Mental Illness and Metabolic Syndrome

This comprehensive session will address the needs of the mental health professionals who care for the large proportion of patients with severe mental illness (SMI) who have cardiometabolic risk factors, in particular, metabolic syndrome. Meta-analyses have indicated that at least 1 out of 3 patients with SMI has metabolic syndrome. This session aims to familiarize the audience with the complex reasons for the elevated risk for metabolic syndrome, as well as highlight the adverse downstream effects, both medically and psychiatrically, and point out clinically useful ways to identify and manage this aspect of health in patients with SMI.


Speakers
avatar for Christoph U. Correll, MD

Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine, Hofstra North Shore Long Island Jewish School of Medicine, Medical Director, Recognition and Prevention (RAP) Program, The Zucker Hillside Hospital, Glen Oaks, New YorkChristoph Correll, MD, is currently a Professor of Psychiatry and... Read More →


Friday September 11, 2015 2:45pm - 4:00pm PDT
20A

2:45pm PDT

Patient Psychoeducation: Effectively Teaching the Relationship of Neurobiology and Psychopharmacology to Manage Key Psychiatric Symptoms

This session will demonstrate a dialogue between a mental health professional and patient with complex symptomatology, including anxiety disorders, bipolar disorder with psychotic features, substance abuse, and posttraumatic stress disorder. The dialogue will focus on how to teach patients the relationship of neurobiology and psychopharmacology with symptom management while ascertaining their lived experience. This session will anchor symptoms in a neurobiological frame of reference to facilitate patient understanding that it is possible to learn to manage symptoms. Mr. Arauz and Dr. Moller will demonstrate how motivational interviewing techniques encourage patients to articulate their lived experience and connect symptoms with their neurobiological origins.


Moderators
avatar for Eric Arauz, MLER

Eric Arauz, MLER

Adjunct Instructor, Rutgers University/Robert Wood Johnson Medical School, Department of Psychiatry, New Brunswick, New JerseyConsidered one of the best pure orators in the United States, Eric Arauz is lead trainer and international keynote speaker through his consulting firm, A.I.E... Read More →

Speakers
avatar for Mary D. Moller, DNP, ARNP, PMHCNS-BC

Mary D. Moller, DNP, ARNP, PMHCNS-BC

Associate Professor, Pacific Lutheran University; Attending Advanced Registered Nurse Practitioner, Metropolitan Development Council, Tacoma, WashingtonMary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN , is an Advanced Registered Nurse Practitioner  who is dually certified as... Read More →


Friday September 11, 2015 2:45pm - 4:00pm PDT
30E

2:45pm PDT

Mental Wellness Matters: Applying Wellness Interventions Even in the Busiest Clinical Practice

Traditionally, mental health has focused on illness rather than wellness. More recently, the field of mental health has adopted the very old concept of wellness into clinical practice. Instead of focusing solely on symptom reduction, some practitioners in mental health have incorporated wellness into their treatment plans. Others have created practices based solely on the concept of wellness. This session will consider the power of creating a wellness-based practice by reviewing its 5 key elements: exercise, meditation, sleep, connectedness, and nutrition. In addition to exploring these 5 wellness principles, Dr. Jain will review a small pilot study researching the combination of such wellness elements in a 30-day program.


Moderators
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Adjunct Clinical Affiliate, University of Texas at Austin, School of Nursing; Executive Director, Mental Health Aerobics Project, Austin, TexasDr. Saundra Jain is the executive director of the Mental Aerobics Project focused on wellness and the impact of positive psychology on client... Read More →

Friday September 11, 2015 2:45pm - 4:00pm PDT
29D

2:45pm PDT

Why Would Patients with Schizophrenia Take Medication? Understanding Adherence Challenges Using a Patient-Centered Approach

When it comes to the topic of adherence to antipsychotic medication for the treatment of schizophrenia, the vast majority of studies focus on nonadherence and how to “correct” nonadherence. This begs the question—why would patients want to take antipsychotic medication anyway? This session will flip the topic around and assume that stopping medication is “normal” given the diagnosis of schizophrenia and that it is our job as clinicians to figure out a patient-centered strategy to help our patients understand in a real way that antipsychotic medication might be worth all of the challenges and difficulties.


Speakers
avatar for Peter Weiden, MD

Peter Weiden, MD

Professor of Psychiatry, University of Illinois Medical Center, Chicago, IllinoisPeter J. Weiden, MD is a Professor of Psychiatry at the University of Illinois Medical Center in Chicago. He is also the Chief Medical Officer at Uptown Research, a clinical trials program specializing... Read More →


Friday September 11, 2015 2:45pm - 4:00pm PDT
28E

4:15pm PDT

Brain Aging and Cognitive Decline: What Mental Health Professionals Need to Know about Detection and Intervention Strategies

Our population is aging rapidly, and memory loss is the most common complaint in individuals 65 years of age and older. Whereas we may have once been resigned to believe that cognitive impairment was an inevitable part of life, data now suggest that appropriate assessment and intervention can protect brain health in our older patients. In this session, Dr. Small will demonstrate how the latest evidence can be translated into practical strategies for diagnosing and treating age-related cognitive decline, including mood disorders that often accompany memory impairment. In addition to highlighting the recent research in this area, Dr. Small will discuss treatments and lifestyle strategies that protect brain health in patients of all ages.


Speakers
avatar for Gary W. Small, MD

Gary W. Small, MD

Professor of Psychiatry; Parlow-Solomon Professor on Aging, David Geffen School of Medicine at University of California, Los Angeles (UCLA); Director, UCLA Longevity Center Stewart & Lynda Resnick Neuropsychiatric Hospital, Los Angeles, CaliforniaIn addition to his role as Director... Read More →


Friday September 11, 2015 4:15pm - 5:30pm PDT
20A

5:45pm PDT

Exhibit Hall Reception
Friday September 11, 2015 5:45pm - 7:15pm PDT
Exhibit Hall San Diego Convention Center

5:45pm PDT

Poster Gala
Friday September 11, 2015 5:45pm - 7:15pm PDT
Exhibit Hall San Diego Convention Center

6:15pm PDT

Psych Congress Network Live!
Friday September 11, 2015 6:15pm - 7:15pm PDT
Exhibit Hall San Diego Convention Center

7:30pm PDT

Professional Medical Education (PME) Presentations

Non-CME. Dinner will be served. Seating is limited.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care. Seating is limited and available on a first come, first served basis. PME presentations are not intended or eligible for CME/CE credit.


Friday September 11, 2015 7:30pm - 8:45pm PDT
TBD1 San Diego Convention Center
 
Saturday, September 12
 

7:30am PDT

ISS: Improving the Recognition and Management of Bipolar Disorder in Adolescents with or without Comorbidities

Adolescents with bipolar disorder often exhibit a variety of symptoms that can be commonly confused with other disorders, resulting in misdiagnosis and inappropriate treatment. This interactive symposium will provide mental health professionals with the tools to differentiate bipolar disorder from other psychiatric disorders in adolescents, and an up-to-date review of available therapies to optimize treatment selection and outcomes in adolescent patients with bipolar disorder.

Psychopharmacology Credit: 0.75

This activity is supported by an educational grant from Allergan.


Co-Chairs
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressClinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine,  Midland, TexasDr. Rakesh Jain attended medical school at the University of Calcutta in India and attended graduate school... Read More →

Steering Committee
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina; Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, North CarolinaDr. Vladimir... Read More →


Saturday September 12, 2015 7:30am - 9:15am PDT
20D

7:30am PDT

ISS: Contemporary Strategies for Improving Schizophrenia Treatment Adherence and Outcomes

Join Dr. Weiden as he outlines expert recommendations and evidence for the use of long acting injectables (LAIs) in patients with early schizophrenia. Safety, efficacy, and the clinical role of LAIs for the management of schizophrenia will be discussed, in addition to addressing how a patient centric treatment approach and shared-decision making can help improve adherence to schizophrenia therapy.

Psychopharmacology Credit: 1.25

This activity is supported by an educational grant from Alkermes, Inc.


Speakers
avatar for Peter Weiden, MD

Peter Weiden, MD

Professor of Psychiatry, University of Illinois Medical Center, Chicago, IllinoisPeter J. Weiden, MD is a Professor of Psychiatry at the University of Illinois Medical Center in Chicago. He is also the Chief Medical Officer at Uptown Research, a clinical trials program specializing... Read More →


Saturday September 12, 2015 7:30am - 9:15am PDT
20BC

9:30am PDT

Obsessive Compulsive Disorder: Mastering Treatment Resistance in 2015

Obsessive compulsive disorder (OCD) is often a hidden disorder that, once discovered, poses challenges to accurate diagnosis and effective treatment. In this session, Dr. Jefferson will explore strategies for a timely diagnosis and effective psychopharmcology to manage symptoms. Common and uncommon comorbidities, as well as ways to integrate nonpharmacologic approaches to treatment, will also be discussed.


Speakers
avatar for James Jefferson, MD

James Jefferson, MD

President Healthcare Technology Systems, Inc, Distinguished Senior Scientist, Madison Institute of Medicine®, Inc; Clinical Adjunct Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin


Saturday September 12, 2015 9:30am - 10:45am PDT
30E

9:30am PDT

To Use or Not to Use Antidepressants for Bipolar Disorder?

Antidepressants are commonly used in bipolar disorder despite limited data to support their efficacy and substantive psychiatric tolerability concerns in this condition. Why do mental health professionals continue to prescribe these agents to treat bipolar? Are antidepressants ever appropriate for patients with this disorder? In this case-based session, Dr. Ketter will draw attention to the strengths and limitations of using antidepressants in bipolar disorder and demontrate how to distinguish bipolar disorder patients who are more likely to encounter problems with antidepressant use.

Session developed in collaboration with the International Bipolar Foundation.


Speakers
avatar for Terrence Ketter, MD

Terrence Ketter, MD

Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; Chief, Bipolar Disorder Clinic, Stanford University ospital and Clinics, Stanford, CaliforniaTerrence Ketter, MD has been at the Department of Psychiatry and Behavioral Sciences in the Stanford... Read More →


Saturday September 12, 2015 9:30am - 10:45am PDT
20A

9:30am PDT

The Other 25%: Understanding the Unique Challenges of Autistic Girls and Women

The majority of individuals with autism spectrum disorders (ASD) are males, and we are only scratching the surface in understanding a comprehensive approach to these patients and the behavioral health problems they encounter. Yet there is another group of autistic patients who are rarely discussed—females on the spectrum face unique challenges, especially during puberty, courtship, motherhood, and employment. Dr. Greenberg will focus on this often overlooked group, delving into issues such as sexuality and inappropriate sexual behaviors, birth control and fertility problems, and how these difficulties impact daily living. This session will also highlight factors that often precipitate a visit to the mental health provider and how we as clinicians can be a resource to these patients and families.


Speakers
avatar for Doris Greenberg, MD

Doris Greenberg, MD

Associate Clinical Professor of Pediatrics, Mercer University School of Medicine, Memorial Health University Medical Center Children's Hospital, Savannah, GeorgiaDoris Greenberg, MD is a full-time Developmental and Behavioral Pediatrician practicing in Savannah, Georgia.  She is... Read More →


Saturday September 12, 2015 9:30am - 10:45am PDT
29D

9:30am PDT

CPT Code Set: The Old, The New, and The Ugly

Mental health professionals continue to struggle with the 2013 CPT code changes. As Medicare and other payers initiate audits, this session will help improve mental health professionals’ knowledge base and documentation abilities. Drs. Shah and Lustig will review the 2013 CPT code changes, introduce new CPT codes for Applied Behavior Analysis, and discuss medical record audits by payers and documentation requirements to support billed services. Additionally, there are new CPT codes for the intensive behavioral interventions that will interest mental health professionals who specialize in autism spectrum disorders.


Speakers
avatar for Vikram Shah, MD, MBA

Vikram Shah, MD, MBA

Lead Medical Director, Cigna, Columbia, MarylandVikram Shah, MD, MBA, is currently a Lead Medical Director at Cigna, a global health service company. He completed his psychiatric training, as well as biological psychiatry fellowship, at the University of Cincinnati. Later, he completed... Read More →
avatar for Stuart Lustig, MD, MPH

Stuart Lustig, MD, MPH

Lead Medical Director, Cigna, Glendale, CaliforniaStuart L. Lustig, MD, MPH is a board certified child and adolescent psychiatrist and Lead Medical Director for Child and Adolescent Care for Cigna's behavioral health business. He also serves as an Associate Clinical Professor in the... Read More →


Saturday September 12, 2015 9:30am - 10:45am PDT
28E

11:00am PDT

New Anti-addiction Medications: Exploring Pharmacogenetic and Immunotherapy Approaches to Managing Addiction
Addiction treatments have been substantially improved in the past 20 years, but some mental health professionals are not aware of how these medications can be utilized in their treatment of patients. This session will review the evidence-based data on nalmefene and naltrexone for alcoholism, doxazosin for cocaine dependence, and vaccines for methamphetamine dependence. Dr. Kosten will discuss how to identify patients who will benefit from these medications based on clinical and genetic characteristics.

Speakers
avatar for Thomas Kosten, MD

Thomas Kosten, MD

JH Waggoner Chair and Professor of Psychiatry, Neuroscience, Pharmacology, and Immunology, Baylor College of Medicine, Houston, TexasThomas R. Kosten, MD, is the JH Waggoner Chair and Professor of Psychiatry, Pharmacology and Neuroscience, vice-Chair for Psychiatry and Co-director... Read More →


Saturday September 12, 2015 11:00am - 12:15pm PDT
30E

11:00am PDT

The DSM-5 and Neurocognitive Disorders: Diagnosis and Treatment Options

The Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) made a number of changes to neurocognitive disorders, including changes to Alzheimer’s dementia and delirium. This session will focus on teaching clinicians about the DSM-5 approach to diagnosing neurocognitive disorders, as well as help clinicians understand pharmacologic and nonpharmacologic approaches to Alzheimer’s disease treatments. Participants will develop skills to assist in earlier diagnosis of Alzheimer’s and other neurocognitive disorders, as well as improve their ability to treat and manage behavioral symptoms of these disorders.


Speakers
avatar for George T. Grossberg, MD

George T. Grossberg, MD

Professor, Department of Neurology and Psychiatry, Department of Anatomy and Neurobiology, Department of Internal Medicine, Division of Geriatric Medicine, Dementia, and Health Aging, St. Louis University School of Medicine, St. Louis, MissouriGeorge T. Grossberg, MD, is the Samuel... Read More →


Saturday September 12, 2015 11:00am - 12:15pm PDT
29D

11:00am PDT

Suicide Prevention: State of the Science for Mental Health Professionals
Suicide is the tenth leading cause of death in the latest nation-wide epidemiological data. One goal of the 2012 National Strategy for Suicide Prevention is to develop and promote effective clinical and professional practices, and there are a number of specific programs and strategies that have been designated as best practices or that approach a standard of care. This session will provide an update for clinicians in empirically-based assessment and management of suicidality and will be led by interprofessional experts in national, VA, and regional initiatives. Morton Silverman, MD, will present the risk assessment and risk formulation of the patient with suicidality. Mark De Santis, PsyD, MS, will describe the use of the Self-Directed Violence (SDV) Classification System Clinical Tool and the patient Safety Plan. Janet York, PhD, RN, will focus on training clinicians in a systematic assessment, management, and tracking system, such as the Collaborative Assessment and Management of Suicidality (CAMS), and its clinical tool, the Suicide Status Form (SSF). Presenters will highlight national initiatives, trends, research, and innovations as they relate to clinical practice and current gaps in knowledge and practice.

Speakers
avatar for Janet A. York, PhD, APRN, BC, PMHCS, FAAN

Janet A. York, PhD, APRN, BC, PMHCS, FAAN

Director of the Psychiatric Mental Health Nurse Practitioner Residency at the Robert Wood Johnson Veteran Affairs (VA) Medical Center; Adjunct Research Professor of Nursing, Medical University of South Carolina; Fellow in the American Academy of NursingJanet York, PhD, PMHCS, BC... Read More →
avatar for Morton Silverman, MD

Morton Silverman, MD

Assistant Clinical Professor of Psychiatry, University of Colorado Denver School of Medicine, Aurora, Colorado; Senior Science Advisor and Distinguished Medical Scholar Suicide Prevention Resource Center, Center for the Study and Prevention of Injury, Violence, and Suicide, Education... Read More →
avatar for Mark L. De Santis, MS, PsyD

Mark L. De Santis, MS, PsyD

Assistant Professor, Department of Psychiatry and Behavioral Sciences, Military Science Division, Medical University of South Carolina Mark L. De Santis, MS, PsyD is a graduate of Nova Southeastern University where he obtained Master’s degrees in both Counseling and Clinical Psychology... Read More →


Saturday September 12, 2015 11:00am - 12:15pm PDT
28E

11:00am PDT

Psychiatric Disorders During Pregnancy and the Postpartum: Treatment of Depression During Pregnancy and the Postpartum (PART 1)

Women of reproductive age suffer in great proportions from mood and anxiety disorders, the treatment of which during pregnancy and the postpartum poses unique dilemmas. In part 1 of this 2-part series, Dr. Freeman will address the ever evolving body of literature regarding pharmacologic management of psychiatric disorders during pregnancy, as well as recent labeling changes issued by the US Food and Drug Administration designed to provide a greater understanding of data pertaining to pregnancy exposure. Part 1 will focus primarily on depression during pregnancy and the postpartum, including implications for breastfeeding.


Speakers
avatar for Marlene Freeman, MD

Marlene Freeman, MD

Associate Professor of Psychiatry, Harvard Medical School, Boston, MassachusettsMarlene P. Freeman, MD, is an Associate Professor of Psychiatry at Harvard Medical School in Cambridge, Massachusetts. She is the Director of Clinical Services, Perinatal, and Reproductive Psychiatry Program... Read More →


Saturday September 12, 2015 11:00am - 12:15pm PDT
20A

12:30pm PDT

Professional Medical Education (PME) Presentations

Non-CME. Lunch will be served. Seating is limited.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives and assess the value to your patient care. Seating is limited and available on a first come, first served basis. PME presentations are not intended or eligible for CME/CE credit.


Saturday September 12, 2015 12:30pm - 1:45pm PDT
TBD1 San Diego Convention Center

1:30pm PDT

Poster Presentations
Saturday September 12, 2015 1:30pm - 2:30pm PDT
Exhibit Hall San Diego Convention Center

2:00pm PDT

Psych Congress Network Live!
Saturday September 12, 2015 2:00pm - 2:30pm PDT
Exhibit Hall San Diego Convention Center

2:45pm PDT

Clinical Pharmacology of Antidepressants and Antipsychotics: How This Information Can Improve Patient Outcomes
Antidepressants and antipsychotics are the most frequently used of all psychiatric medications. Many prescribers were not trained to conceptualize them in terms of their clinical pharmacology (ie, pharmacodynamics and pharmacokinetics), yet this is critical to understanding how these medications affect patients, including why some patients do not respond as expected of the “usual” patient. This session will explain a means of understanding the medications classified as antidepressants and antipsychotics in terms of their pharmacodynamics and pharmacokinetics that will help mental health professionals develop better treatment plans for patients and make better mid-course corrections when needed.

Speakers
avatar for Sheldon Preskorn, MD

Sheldon Preskorn, MD

President and Chief Executive Officer, Clinical Research Institute; Professor, Department of Psychiatry. University of Kansas School of Medicine, Wichita, KansasSheldon H. Preskorn, M.D., is Professor in the Department of Psychiatry at the University of Kansas School of Medicine-Wichita... Read More →


Saturday September 12, 2015 2:45pm - 4:00pm PDT
30E

2:45pm PDT

Psychiatric Disorders During Pregnancy and the Postpartum: Treatment Dilemmas in Pregnancy—A Focus on Bipolar Disorder, Postpartum Psychosis, Anxiety, and ADHD (PART 2)

Part 2 of this 2-part women’s mental health series will take an in-depth look at the common presentation and risks for bipolar disoder, postpartum psychosis, anxiety, and attention-deficit/hyperactivity disorder (ADHD) in women of childbearing age. Dr. Freeman will examine the risks and benefits for using mood stabilizers, antipsychotics, stimulants, and anxiolytics during pregnancy and postpartum, including fetal exposure and the impact of these medications in breastfeeding.


Speakers
avatar for Marlene Freeman, MD

Marlene Freeman, MD

Associate Professor of Psychiatry, Harvard Medical School, Boston, MassachusettsMarlene P. Freeman, MD, is an Associate Professor of Psychiatry at Harvard Medical School in Cambridge, Massachusetts. She is the Director of Clinical Services, Perinatal, and Reproductive Psychiatry Program... Read More →


Saturday September 12, 2015 2:45pm - 4:00pm PDT
20A

2:45pm PDT

Mechanism of Action of Insomnia Medications: Implications for Clinical Practice

Insomnia is the second most commonly encountered symptom in clinical medicine, reported by 80% of psychiatric patients. It is also one of the most challenging complaints in psychiatric practice, as it complicates the care of many mental illnesses. Although numerous hypnotic agents are available for insomnia management, they are predominantly agents with the same mechanism (ie, activation at the GABA-BZ receptor complex). Over the past few years, however, a variety of agents have been introduced with several more under development that possess novel mechanisms for the management of insomnia. These agents have introduced the possibility of enhanced safety and unique suitability for specific psychiatric populations. This session will review the basic sleep mechanisms and traditional GABA-ergic medications, as well as novel agents acting as melatonin, histamine, and orexin receptors. It will also present strategies for tailoring available pharmacologic agents to the patient’s clinical need to optimize clinical efficacy.


Speakers
avatar for Karl Doghramji, MD

Karl Doghramji, MD

Professor of Psychiatry, Neurology, and Medicine, Medical Director, Jefferson Sleep Disorders Center, Program Director, Fellowship in Sleep Medicine, Thomas Jefferson University, Philadelphia, PennsylvaniaKarl Doghramji, MD, is a Professor of Psychiatry, Neurology, and Medicine at... Read More →


Saturday September 12, 2015 2:45pm - 4:00pm PDT
28E

2:45pm PDT

Occupational Stress First Aid

Research has established the deleterious effects of both acute and chronic occupational stress on health, wellness, productivity, and job satisfaction. Employing a stress first aid model that leverages preclinical health promotion and illness prevention measures has great potential to positively influence occupational health and wellness. This session will examine the US Navy and Marine Corp’s Occupational Stress Continuum and Stress First Aid models as preclinical interventions that target occupational stress-related injury and illness, and discuss ways in which to incorporate these models into your practice.


Speakers
avatar for Richard Westphal, PhD, RN, PMHCNS-BC

Richard Westphal, PhD, RN, PMHCNS-BC

Professor, Department of Family, Community, and Mental Health Systems, University of Virginia, School of Nursing, Charlottesville, Virginia; Independent Consultant for Psychological Health and Wellness Interventions, Programs, and Health Policy, Gordonsville, VirginiaRichard Westphal... Read More →
avatar for Sean P. Convoy, RN, DNP, PMNHP-BC

Sean P. Convoy, RN, DNP, PMNHP-BC

Associate Professor, Virginia Commonwealth University, Richmond, Virginia; Psychiatric Mental Health Nurse Practitioner, Carolina Psychological Health Services, Jacksonville, North CarolinaSean P. Convoy, MSN, PMHNP-BC, CDR, USN, Retired, is an Assistant Professor and adjunct faculty... Read More →


Saturday September 12, 2015 2:45pm - 4:00pm PDT
29D

4:15pm PDT

Screening, Diagnosing, and Treating ADHD in Preschool Children: What Does the Evidence Say?

Despite the paucity of FDA-approved treatments for attention-deficit/hyperactivity disorder (ADHD) in preschool aged children and the relative dearth of well-controlled clinical research in this population, increasing numbers of preschoolers are being treated for ADHD. In this session, Dr. Donnelly will present state-of-the art research evidence for psychosocial and pharmacologic treatments in this age group. Participants will receive practical clinical guidance, as well as a review of the major practice parameter guidelines of clinical relevance for screening, diagnosing, and treating ADHD in this vulnerable population.


Speakers
avatar for Craig Donnelly, MD

Craig Donnelly, MD

Program Director, Child & Adolescent Psychiatry, Professor of Psychiatry & Pediatrics, Geisel School of Medicine, Dartmouth Medical Center, Hanover, New HampshireCraig L. Donnelly, MD, is currently Chief of Child and Adolescent Psychiatry and Professor of Psychiatry and Pediatrics... Read More →


Saturday September 12, 2015 4:15pm - 5:30pm PDT
29D

4:15pm PDT

See No Evil, Hear No Evil, Speak No Evil: Reconsidering Benzodiazepine Use in an Era of Increasing Concern
Benzodiazepines continue to prove to be an effective clinical intervention in the management of anxiety disorders and insomnia and are widely utilized in clinical practice. Over the last 2 years, multiple lines of evidence reveal potential adverse outcomes for patients who are taking benzodiazepines, including increased risk of falls and addiction. We clinicians are understandably confused: Do we use benzodiazepines? Do we not use benzodiazepines? What do we do with those patients who are already taking benzodiazepines? The goal of this session is to engage attendees in a much-needed conversation about the risk-benefit ratio of using benzodiazepines. Drs. Saundra and Rakesh Jain will review the pros and cons associated with the use of benzodiazepines, as well as withdrawal/tapering schedules. The roles of nonpharmacologic and pharmacologic interventions in the withdrawal/tapering process will also be presented.

Moderators
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Adjunct Clinical Affiliate, University of Texas at Austin, School of Nursing; Executive Director, Mental Health Aerobics Project, Austin, TexasDr. Saundra Jain is the executive director of the Mental Aerobics Project focused on wellness and the impact of positive psychology on client... Read More →
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressClinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine,  Midland, TexasDr. Rakesh Jain attended medical school at the University of Calcutta in India and attended graduate school... Read More →

Saturday September 12, 2015 4:15pm - 5:30pm PDT
28E

4:15pm PDT

The Detection of Malingering and Deception

Many mental health professionals have no training in detecting malingered mental illness. Since deinstitutionalization, it has become much more difficult for patients to be admitted to private psychiatric hospitals and state hospitals. Some patients resort to grossly exaggerating their symptoms and others make up symptoms for “3 hots and a cot.” The goal of this session is to provide mental health professionals with clues and signs to detect lies and to distinguish between feigned and genuine psychotic symptoms. Mental health professionals will be able to provide appropriate assistance to patients desperate enough to misrepresent their symptoms and better utilize limited mental health resources.


Speakers
avatar for Phillip Resnick, MD

Phillip Resnick, MD

Professor of Psychiatry, Case Western Reserve University, Cleveland, OhioPhillip J. Resnick, MD is a Professor of Psychiatry and Director, Division of Forensic Psychiatry at Case School of Medicine in Cleveland, Ohio. Dr. Resnick served as a consultant in many high profile cases... Read More →


Saturday September 12, 2015 4:15pm - 5:30pm PDT
30E

5:45pm PDT

The Center Cannot Hold: My Journey Through Madness

In this highly personal featured session, Dr. Saks will begin by narrating the story of her own struggles with schizophrenia to provide a window into the mind of someone suffering from psychosis. The presentation will challenge the audience to see mental illness through the eyes of their patients, with the ultimate goal of increasing understanding and reducing stigma of schizophrenia and other psychotic disorders. Dr. Saks will then shift gears to focus on ethical dimensions of psychiatric research and forced treatment of patients with mental illness. Issues surrounding right/competency to make treatment decisions will be discussed.


Speakers
avatar for Elyn Saks, PhD, JD

Elyn Saks, PhD, JD

Orrin B. Evans Professor of Law, Psychology, and Psychiatry and the Behavioral Sciences, USC Gould School of Law, Los Angeles, CaliforniaElyn R. Saks, JD, PhD is an Orrin B. Evans Professor of Law, Psychology, and Psychiatry of Behavioral Sciences at the University of Southern California... Read More →


Saturday September 12, 2015 5:45pm - 7:00pm PDT
20A

7:15pm PDT

Professional Medical Education (PME) Presentations

Non-CME, Dinner will be served. Seating is limited.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives and assess the value to your patient care. Seating is limited and available on a first come, first served basis. PME presentations are not intended or eligible for CME/CE credit.


Saturday September 12, 2015 7:15pm - 8:30pm PDT
TBD1 San Diego Convention Center
 
Sunday, September 13
 

7:30am PDT

ISS: Contemporary Approaches to MDD: Improving Adherence and Outcomes

The goal of this symposium is to help mental health professionals stay up-to-date on current and newer pharmacotherapies for the treatment of major depressive disorder (MDD). This symposium will focus on the importance of using validated instruments to improve treatment adherence and the role of shared decision making to optimize treatment outcomes in patients with MDD.

Psychopharmacology Credit: 0.75

This activity is supported by an educational grant from Allergan.


Co-Chairs
avatar for Charles Raison, MD

Charles Raison, MD

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressMike and Mary Sue Endowed Chair in Mind, Body, and Family Well-being Professor; School of Human Ecology Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin, Madison, WisconsinDr... Read More →

Steering Committee
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Adjunct Clinical Affiliate, University of Texas at Austin, School of Nursing; Executive Director, Mental Health Aerobics Project, Austin, TexasDr. Saundra Jain is the executive director of the Mental Aerobics Project focused on wellness and the impact of positive psychology on client... Read More →


Sunday September 13, 2015 7:30am - 9:15am PDT
20BC

9:30am PDT

Clinical Pitfalls Caused by Drug-Drug and Drug-Gene Interactions

Psychiatric medications are often an important component of a patient’s treatment. Nevertheless, drug-drug interactions (STET) and drug-gene interactions can profoundly alter the response to a drug regimen with clinical outcomes ranging from increased efficacy or loss of efficacy to clinically meaningful or life-threatening adverse effects. This session will review the growth in knowledge of DDIs and DGIs that have occurred over the past 20 years. Dr. Preskorn will provide practical tips on how to integrate these concepts into everyday practice.


Speakers
avatar for Sheldon Preskorn, MD

Sheldon Preskorn, MD

President and Chief Executive Officer, Clinical Research Institute; Professor, Department of Psychiatry. University of Kansas School of Medicine, Wichita, KansasSheldon H. Preskorn, M.D., is Professor in the Department of Psychiatry at the University of Kansas School of Medicine-Wichita... Read More →


Sunday September 13, 2015 9:30am - 10:45am PDT
30E

9:30am PDT

Clinical Implications of the Changes to the Mood Disorders in the DSM-5

The release of the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 represented the first significant revision of the diagnostic manual in 20 years. Many of the changes, especially in the mood disorders section, were intended to enhance clinician recognition of new disorders and specifiers that have specific treatment implications. Through a series of case vignettes, Dr. First will outline the changes to the mood disorders in the DSM-5 and highlight those modifications intended to improve decision-making about patient management. Controversies surrounding some of these changes will also be discussed.


Speakers
avatar for Michael B. First, MD

Michael B. First, MD

Professor of Clinical Psychiatry, Columbia University, New York, New YorkMichael B. First MD, is a Professor of Clinical Psychiatry at Columbia University, and is a Research Psychiatrist at the Biometrics Department at the New York State Psychiatric Institute and maintains a schematherapy... Read More →


Sunday September 13, 2015 9:30am - 10:45am PDT
28E

9:30am PDT

What is the Role for Mental Health Professionals in Pain Management?

Patients with chronic pain typically see many specialists, and communication among these providers and with the patient is essential for successful pain management. Yet although multimodal approaches are common, the role of the mental health professional in pain management has not been well defined. Is this an area where behavioral and psychopharmacologic intervention may improve patient outcomes? Should mental health professionals be involved in the care of patients with chronic pain? This session will explore answers to these questions and evaluate the role of the mental health provider in pain management.


Speakers
avatar for Charles Argoff, MD

Charles Argoff, MD

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, New York


Sunday September 13, 2015 9:30am - 10:45am PDT
29D

11:00am PDT

Are Anti-inflammatory Agents Antidepressants: Truth or Dare?
Little is of more current interest to practicing mental health professionals than the question of whether anti-inflammatory agents may hold promise for the treatment of major depression. This interest is based on a multitude of studies showing that inflammation can cause depression and that patients with depression—as a group—have elevated levels of inflammatory biomarkers. Interest has been further stoked by the recent publication of a high-profile meta-analysis that on casual reading suggests that anti-inflammatory agents do have antidepressant properties. In this session, Dr. Raison will review best available data and address the surprising possibility that anti-inflammatory agents can both improve and worsen depressive symptoms. Dr. Raison will provide a much needed cautionary “brake” on the field’s mad rush to utilize anti-inflammatory strategies in depression and demonstrate how inflammatory considerations highlight the fact that major depression is not homogeneous enough to ever be responsive to any type of one-size-fits-all “magic bullet” treatment approach.

Moderators
avatar for Charles Raison, MD

Charles Raison, MD

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressMike and Mary Sue Endowed Chair in Mind, Body, and Family Well-being Professor; School of Human Ecology Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin, Madison, WisconsinDr... Read More →

Sunday September 13, 2015 11:00am - 12:15pm PDT
20A

11:00am PDT

From Circuits to Solutions: Neurobiologically Informed Treatment for Children and Adolescents with Bipolar Spectrum Disorders

A deeper understanding of pediatric bipolar spectrum disorders has been gained in recent years through neuroimaging and neuropsychologic testing, both of which implicate specific brain regions and functions that are distinct among children and adolescents with these disorders. Such research has led to exciting new interventions that incorporate these findings to specifically address these circuitry connections. In this session, Dr. Carbray will highlight the latest data and discuss how to integrate theoretical underpinnings of brain circuitry dysfunction into neurobiologically informed treatments for children and adolescents affected by pediatric bipolar spectrum disorders.

Developed in collaboration with the International Bipolar Foundation.


Speakers
avatar for Julie Carbray, PhD, FPMHNP, PMHCNS

Julie Carbray, PhD, FPMHNP, PMHCNS

Clinical Professor of Psychiatry and Nursing, University of Illinois at Chicago, Chicago, Illinois; Administrative Director, Pediatric Mood Disorder Clinic, Pediatric Brain Research and Intervention Center, Department of Psychiatry, Chicago, IllinoisJulie Carbray, PhD, APN, FPMHNP... Read More →


Sunday September 13, 2015 11:00am - 12:15pm PDT
28E

11:00am PDT

Avoiding Polypharmacy in the Pharmacologic Treatment of Borderline Personality Disorder

There is no evidence for the effectiveness of polypharmacy in the treatment of borderline personality disorder (BPD), yet clinical experience reveals that many patients with BPD often take 2 or more medications simultaneously. In addition to the lack of data to support clinical improvement from this multiple psychotropic medication approach, the use of polypharmacy has a much greater chance of inducing adverse effects and weight gain than it does in leading to clinical improvement. This session will review the value, as well as the limitations, of psychopharmacologic treatment in BPD in order to mitigate the current propensity toward polypharmacy.


Speakers
avatar for Kenneth Silk, MD

Kenneth Silk, MD

Professor Emeritus of Psychiatry, University of Michigan Health System, Ann Arbor, MichiganKenneth Silk, MD went to Brandeis University and then to Albert Einstein College of Medicine in the Bronx. He did a pediatric internship at Montefiore Hospital in the Bronx and a residency in... Read More →
avatar for Victor Hong, MD

Victor Hong, MD

Clinical Instructor, Department of Psychiatry, University of Michigan Health System, Ann Arbor, MichiganVictor Hong, MD attended the University of California at Berkeley, where he received his bachelor’s degree in English Literature, then Loma Linda University School of Medicine... Read More →


Sunday September 13, 2015 11:00am - 12:15pm PDT
30E

11:00am PDT

Summary of the ABPN MOC Program: Life-Long Learning for Psychiatrists

Have you completed your American Board of Psychiatry and Neurology, Inc. (ABPN) Maintainence of Certification (MOC) requirements? All psychiatrists certified by the ABPN after 1994 are required to take part in the MOC program, yet many remain unclear as to where to begin the process. This session, led by MOC Ambassador Dr. Rita Hargrave, will provide an easy-to-follow road map to MOC, outlining the rationale and backround of MOC, as well as the 4-part ABPN MOC program components.  


Speakers
avatar for Rita Hargrave, MD

Rita Hargrave, MD

Clinical Instructor, University of California, Oakland, California; Geriatric Psychiatrist, Martinez VA Hospital, Martinez, CaliforniaRita Hargrave, MD is a board certified geriatric psychiatrist at the Veteran’s Administration Martinez Outpatient Mental Health Clinic and consulting... Read More →


Sunday September 13, 2015 11:00am - 12:15pm PDT
29D

12:30pm PDT

ISS: Generalized Anxiety Disorder: Overcoming Clinical Challenges to Individualized Care

Anxiety disorders are collectively the most prevalent mental illnesses in the US. Generalized anxiety disorder (GAD), in particular, is often misidentified and consequently mismanaged with less than 20% of all patients receiving adequate care. The goal of this symposium is to identify overlapping disorders that may confound GAD treatment, addressing their implications for individualized management strategies   as well as discuss the latest clinical data on available and emerging pharmacotherapies for the treatment of GAD.

Psychopharmacology Credit: 0.25

This activity is supported by an educational grant from Allergan.


Speakers
avatar for Murray B. Stein, MD

Murray B. Stein, MD

Professor of Psychiatry and Family and Preventive Medicine, University of California, San Diego; Staff Psychiatrist, VA San Diego Healthcare System, La Jolla, CaliforniaMurray B. Stein MD, MPH, FRCPC, is Professor of Psychiatry and Family and Preventive Medicine at the University... Read More →


Sunday September 13, 2015 12:30pm - 1:45pm PDT
20D

2:00pm PDT

Ethical Issues in Psychopharmacology

The relative explosion in psychopharmacology over recent decades has placed a variety of useful medications in our therapeutic armamentarium, offering a number of treatment modalities and challenging the mental health professional to keep track of new developments and clinical findings. However, less attention has focused on what might be called the ethical underpinnings of this specialty field—an area that takes us beyond the science of prescribing and into the ethics of prescribing. This oversight creates both knowledge and practice gaps. This session draws not only on theory and decision-making paradigms, but also on Dr. Gutheil’s extensive experience as an expert witness and consultant in the medicolegal arena. The goal of this session is to underscore ethical issues in psychopharmacologic prescribing, provide analyses of commonly encountered ethical dilemmas faced by mental health professionals, as well as review case examples illustrating the problems that may arise in clinical practice.


Speakers
avatar for Thomas Gutheil, MD

Thomas Gutheil, MD

Professor of Psychiatry, Beth Massachusetts Mental Health Center, Harvard Medical School, Boston, MassachusettsThomas G. Gutheil, MD is Professor of Psychiatry in the Department of Psychiatry, Beth Israel-Deaconess Medical Center, Harvard Medical School. Dr. Gutheil has been associated... Read More →


Sunday September 13, 2015 2:00pm - 3:15pm PDT
30E

2:00pm PDT

Practical Strategies for Positive Psychiatry in Later Life

Much of current clinical psychiatry, especially for older adults, is focused on assessment and pharmacologic treatment of mental and/or cognitive disorder symptoms despite recent medical and psychological research that has shown limitations of the present practice. In contrast, there is mounting evidence pointing toward the value of assessing and strengthening positive traits such as resilience, self-efficacy, and social engagement in our elderly patients. Additionally, the use of technology in medicine has increased, yet most mental health professionals have not been trained to utilize these methods in routine practice. This session will discuss clinical strategies for promoting resilience, wisdom, and optimism in older adults with mental illnesses, providing practical suggestions for those seeking to assess and enhance the well-being and overall health of their aging patients.


Speakers
avatar for Dilip V. Jeste, MD

Dilip V. Jeste, MD

Senior Associate Dean for Healthy Aging and Senior Care, Estelle and Edgar Levi Chair in Aging, Distinguished Professor of Psychiatry and Neurosciences, Director, Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, San Diego, CaliforniaDilip V... Read More →


Sunday September 13, 2015 2:00pm - 3:15pm PDT
29D

2:00pm PDT

Seeking a Peaceful Sleep: Treating Traumatic Stress Nightmares Using Psychotherapy and Medications

Trauma survivors often report suffering from dreams that reference traumatic incidents. The re-occurrence of trauma memories during sleep has long-term negative ramifications and emotional impact among survivors. If providers are knowledgeable about techniques to address recurrent nightmares, then they are more likely to effectively facilitate appropriate interventions to decrease nightmares, enhance sleep, and improve overall functioning. The goal of this session is to educate practitioners about interventions that can improve the quality of sleep for their patients struggling with chronic posttraumatic stress disorder by using medication and psychotherapy. Through their respective clinical experience, the presenters will share practical methods to assess and treat one of the most distressing symptoms of traumatic stress: recurrent, traumatically-based nightmares.


Speakers
avatar for Lori Daniels, PhD, LCSW

Lori Daniels, PhD, LCSW

Social Worker/Counselor, Portland Vet Center, Deptartment of Veterans Affairs, Portland, Oregon; Adjunct Instructor, School of Social Work, University of Southern California, Virtual Academic Center, Portland, OregonLori Daniels, PhD, LCSW is currently the military sexual trauma psychotherapist... Read More →
avatar for James Boehnlein, MD, MSc

James Boehnlein, MD, MSc

Professor of Psychiatry, Oregon Health & Science University, Portland, Oregon; Associate Director for Education, Department of VAMC, Northwest Network MIRECC, Portland, OregonAfter completing medical school at Case Western Reserve University, and psychiatry residency training at Oregon... Read More →


Sunday September 13, 2015 2:00pm - 3:15pm PDT
28E

3:30pm PDT

When the Healers Are Mortally Wounded: Clinician Suicide

Our focus as mental health professionals rightly falls to the patient portion of the therapeutic dyad.  However, recent research reveals that clinicians are at risk for some of the same negative outcomes as patients with respect to depression and substance use. Over 400 physicians commit suicide annually, often influenced by preventable and predictable risk factors. This session will highlight the problems of clinician mental illness, lack of self-care, and comorbid substance abuse that can increase risks of serious adverse events, including suicide. The presenters will review the literature around clinician suicide, provide a case-based exploration of salient themes, and offer evidence-based approaches for self-care and professional support.


Moderators
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Adjunct Clinical Affiliate, University of Texas at Austin, School of Nursing; Executive Director, Mental Health Aerobics Project, Austin, TexasDr. Saundra Jain is the executive director of the Mental Aerobics Project focused on wellness and the impact of positive psychology on client... Read More →
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressClinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine,  Midland, TexasDr. Rakesh Jain attended medical school at the University of Calcutta in India and attended graduate school... Read More →

Speakers
avatar for W. Clay Jackson, MD, DipTh

W. Clay Jackson, MD, DipTh

Clinical Assistant Professor of Psychiatry, University of Tennessee College of Medicine, Memphis, TennesseeDr. Jackson is a Clinical Assistant Professor of Psychiatry at the University of Tennessee College of Medicine in Memphis, Tennessee, where he maintains a private practice in... Read More →


Sunday September 13, 2015 3:30pm - 4:45pm PDT
30E

4:45pm PDT

Psych Congress 2015: Final Thoughts and Panel Discussion

Join Psych Congress 2015 Co-Chairs, Drs. Rakesh Jain and Charles Raison, and the entire Steering Committee for an interactive “wrap up” and panel discussion, focusing on conference highlights from the previous 4 days of educational sessions.


Moderators
avatar for Eric Arauz, MLER

Eric Arauz, MLER

Adjunct Instructor, Rutgers University/Robert Wood Johnson Medical School, Department of Psychiatry, New Brunswick, New JerseyConsidered one of the best pure orators in the United States, Eric Arauz is lead trainer and international keynote speaker through his consulting firm, A.I.E... Read More →
avatar for Jon W. Draud, MD, MS

Jon W. Draud, MD, MS

Clinical Professor of Psychiatry, University of Tennessee College of Medicine, Memphis, Tennessee; Medical Director of Psychiatry, Trust Point Psychiatric Hospital and St. Thomas Rutherford Hospital; Medical Director and Principal, Evelyn Frye Associates; Private Practice, Adult and... Read More →
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Adjunct Clinical Affiliate, University of Texas at Austin, School of Nursing; Executive Director, Mental Health Aerobics Project, Austin, TexasDr. Saundra Jain is the executive director of the Mental Aerobics Project focused on wellness and the impact of positive psychology on client... Read More →
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressClinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine,  Midland, TexasDr. Rakesh Jain attended medical school at the University of Calcutta in India and attended graduate school... Read More →
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, South Carolina; Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, North CarolinaDr. Vladimir... Read More →
avatar for Andrew Penn, RN, MS, NP, APRN-BC

Andrew Penn, RN, MS, NP, APRN-BC

Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CAAndrew Penn was trained as an adult nurse practitioner and psychiatric clinical nurse specialist at the University of California, San Francisco... Read More →
avatar for Charles Raison, MD

Charles Raison, MD

Co-Chair, 2015 U.S. Psychiatric and Mental Health CongressMike and Mary Sue Endowed Chair in Mind, Body, and Family Well-being Professor; School of Human Ecology Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin, Madison, WisconsinDr... Read More →

Sunday September 13, 2015 4:45pm - 5:15pm PDT
30E